Restricted accessResearch articleFirst published online 1981-12
Resistance to Moloney Murine Sarcoma Virus (M-MuSV) Tumor Induction is Associated with Natural Antibody Production to «Endogenous» Moloney Leukemia Virus (M-MuLV) in Balb/Mo Mice
BALB/Mo mice are characterized by early expression of « endogenized » M-MuLV and are resistant to M-MuSV tumor induction. Furthermore, compared to normal BALB/c mice, sera from BALB/Mo mice exhibit a significant reactivity which is specific for M-MuLV when tested in a 125I-labelled Staphylococcus protein A binding assay. The possible significance of this reactivity in conferring tumor resistance is explored.
Get full access to this article
View all access options for this article.
References
1.
BatzingB.L., YurconicM., HannaM.G.: Autogenous immunity to endogenous RNA tumor virus: Chronic humoral immunoresponse to virus envelope antigens in B6C3F1 mice.J. Natl. Cancer Inst., 52: 117–131, 1974.
2.
BreindlM., DausmanS., JaenischR., DoehmerJ., VilleckeK.: Germ line integration of Moloney leukemia virus: Identification of the chromosomal integration site by somatic cell genetics.Proc. Natl. Acad. Sci. USA, 76: 1938–1942, 1979.
3.
BrownJ.B., KlitzmanJ.M., HellstroemK.E.: A microassay for antibody binding to tumor cell surface antigens using I125-labelled protein A from Staphylococcus aureus. J.Immunol. Methods, 15: 57–66, 1977.
4.
Chieco-BianchiL., ColombattiA., CollavoD., SendoF., AokiT., FischingerP.S.: Tumor induction by murine sarcoma virus in AKR and C58 mice.Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. J. Exp. Med., 140: 1162–1179, 1974.
5.
Chieco-BianchiL.: Some immunologic problems in oncogenesis by type-C RNA viruses.Acta Med. Rom., 13: 235–242, 1975.
6.
Chieco-BianchiL., ColombattiA., De RossiA., D'AndreaE.: Role of endogenous C-type viruses in tumorigenesis by exogenous oncogenic viruses. In: Advances in medical oncology, research and education. Vol. 1, Carcinogenesis. pp. 61–69, MargisonG.P. (Ed.), Pergamon Press, Oxford, New York, 1979.
7.
CollavoD., ColombattiA., Chieco-BianchiL., DaviesA.J.S.: T lymphocyte requirement for MSV tumour prevention or regression.Nature, 249: 169–170, 1974.
8.
ColombattiA., CollavoD., BiasiG., Chieco-BianchiL.: Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype.I. Genetics of resistance in AKR mice. Int. J. Cancer, 16: 427–434, 1975.
9.
ColombattiA., CollavoD., BiasiG., Chieco-BianchiL.: Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype. III. Possible correlation with endogenous virus production. In: Comparative Leukemia Research, 1975, Bibl. Haemat., No. 43.ClemmensenJ., and YohnD.S. (Eds.), Karger, Basel, pp. 448–450, 1976.
10.
ColombattiA., Chieco-BianchiL., De RossiA., CollavoD.: Genetics of murine sarcoma virus (MSV)-induced tumors in AKR mice: Evidence that late progressing and early regressing tumors are controlled by different genes.Int. J. Cancer, 19: 565–575, 1977.
11.
ColombattiA., De RossiA., TaylorB.A., Chieco-BianchiL., MeierH.: Relationship between Moloney MSV tumor resistance and endogenous virogene expression in AKR mouse strain and its hybrids.Int. J. Cancer, 21: 179–185, 1979.
12.
ColombattiA., HilgersJ.: A radioimmunoassay for virus antibody using binding of 125I-labelled protein A.J. Gen. Virol., 43: 395–401, 1979.
13.
ColombattiA., De RossiA., HilkensJ., CollavoD., Chieco-BianchiL.: Age dependance and genetics of expression of ecotropic murine leukemia virus in SJL/J mice.J. Natl. Cancer Inst., 62: 1451–1457, 1979.
14.
EllisR.W., StockertE., FleissnerE.: Association of endogenous retroviruses with radiation-induced leukemias of BALB/c mice.J. Virol., 33: 652–660, 1980.
15.
GodingJ.W.: Uses of Staphylococcal protein A as an immunological reagent.J. Immunol. Methods, 20: 241–253, 1978.
16.
GreenwoodF.C., HunterW.M., GloverJ.S.: The preparation of 131I-labelled human growth hormone of high specific activity.Biochem. J., 89: 114–123, 1963.
17.
HaysE.F., VredevoeD.L.: A discrepancy in XC and oncogenicity assays for murine leukemia virus in AKR mice.Cancer Res., 37: 726–730, 1977.
18.
HuebnerR.S., TodaroG.S.: Oncogenes of RNA tumor viruses as determinants of cancer.Proc. Natl. Acad. Sci. USA, 64: 1087–1094, 1969.
IhleJ.N., HannaM.G., RobersonL.E., KenneyF.T.: Autogenous immunity to endogenous RNA tumor virus: Identification of antibody reactivity to select viral antigens.J. Exp. Med., 139: 1568–1581, 1974.
21.
IhleJ.N., BengalikMcEwan R.: Radiation leukemia in C57BL/6 mice.I. Lack of serological evidence for the role of endogenous ecotropic viruses in pathogenesis. J. Exp. Med., 144: 1391–1405, 1976.
22.
IhleN., JosephD.R., PazminoN.H.: Radiation leukemia in C57/BL/6 mice.II. Lack of ecotropic virus expression in the majority of lymphomas. J. Exp. Med., 144: 1406–1423, 1976.
23.
IhleJ.N., LazarB.: Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity.J. Virol., 21: 974–980, 1977.
24.
InleJ.N., HannaM.G.: Natural immunity to endogenous onco-RNA virus in mice. In: Contemporary Topics in Immunobiology, vol. 6, pp. 169–194. HannaM.G., and RappF. (Eds.), Plenum Press, New York, 1977.
25.
JaenischR., FanH., CrokerB.: Infection of pre-implantation mouse embryos and of newborn mice with leukemia virus; tissue distribution of viral DNA and RNA and leukemogenesis in the adult animal.Proc. Natl. Acad. Sci. USA, 72: 4008–4012, 1975.
26.
JaenischR.: Germ line integration and mendelian transmission of the exogenous Moloney leukemia virus.Proc. Natl. Acad. Sci. USA, 73: 1260–1264, 1976.
27.
JaenischR.: Germ line integration of Moloney leukemia virus: effect of homozygosity at the M-MuLV locus.Cell, 12: 691–696, 1977.
28.
JaenischR.: Moloney leukemia virus gene expression and gene amplification in pre-leukemic and leukemic BALB/Mo mice.Virology, 93: 80–90, 1979.
29.
JolicoeurP., RosenbergN., CotelessaA., BaltimoreD.: Leukemogenicity of clonal isolates of murine leukemia viruses.J. Natl. Cancer Inst., 60: 1473–1476, 1978.
30.
KesslerS.W.: Rapid isolation of antigens from cells with a Staphylococcal protein A-antibody adsorbent: Parameters of the interaction of antibody-antigen complex with protein A.J. Immunol., 115: 1617–1624, 1975.
31.
LernerR.A., WilsonC.B., Del VillanoB.C., McConaheyP.X., DixonF.S.: Endogenous oncornaviral gene expression in adult and fetal mice: Quantitative, histologic, and physiologic studies of the major viral glycoprotein gp 70.J. Exp. Med., 143: 151–166, 1976.
32.
LevyJ.A.: Endogenous C-type viruses in normal and « abnormal » cell development.Cancer Res., 37: 2957–2968, 1977.
33.
LevyJ.P., LeclercJ.C.: The murine sarcoma virus-induced tumor: Exception or general model in tumor immunology?Adv. Cancer Res., 24: 1–66, 1977.
34.
MackenzieM.R., WarnerN.L., MitchellG.F.: The binding of murine immunoglobulins to Staphylococcal protein A.J. Immunol., 120: 1493–1496, 1978.
35.
MackenzieM.R., GutmanG.A., WarnerN.L.: The binding of murine IgM to Staphylococcal A protein.Scand. J. Immunol, 7: 367–370, 1978.
36.
MartinS.E., MartinW.J.: Naturally occurring cytotoxic tumor reactive antibodies directed against type C viral envelope antigens.Nature, 256: 498–499, 1975.
37.
MénardS., ColnaghiM.I., Della PortaG.: Comparison of the natural humoral antitumor reactivity of different strains of mice.Tumori, 66: 13–26, 1980.
38.
MoloneyJ.B.: A virus-induced rhabdomyosarcoma of mice.Natl. Cancer Inst. Monogr., 22: 139–142, 1966.
39.
NowinskiR.L., KaehlerS.L.: Antibody to leukemia virus: Widespread occurrence in mice.Science, 185: 869–871, 1974.
40.
NowinskiR.C., KaehlerS.L., BurgessR.R.: Immune response in the mouse to endogenous leukemia viruses.Cold Spring Harbor Symp. Quant. Biol., 39: 1123–1128, 1975.
41.
NowinskiR.C., KleinP.A.: Anomalous reactions of mouse alloantisera with cultured tumor cells.II. Citotoxicity is caused by antibodies to leukemia viruses. J. Immunol., 115: 1261–1268, 1975.
42.
NowinskiR.C., KaehlerS.L., BaronJ.: Genetic control of natural immunity to ecotropic mouse leukemia viruses: Production of endogenous immunogen.Infect. Immun., 13: 1091–1097, 1976.
43.
NowinskiR.C., LoestromM.E., TarnM.R., StoneM.R., BurnetteW.N.: The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses.Virology, 93: 111–126, 1979.
44.
ObataY., StockertE., O'DonnelP.V., OkuboJ., SneyderH.W., OldL.J.: G(RADA 1): A new cell surface antigen of mouse leukemia defined by naturally occurring antibody and its relationship to murine leukemia virus.J. Exp. Med., 147: 1099–1105, 1978.
45.
OldstoneM.B.A., AokiT., DixonF.J.: The antibody response of mice to murine leukemia virus in spontaneous infection: Absence of classical immunological tolerance.Proc. Natl. Acad. Sci. USA, 69: 134–138, 1972.
46.
OldstoneM.B.H., Del VillanoB.C., DixonF.S.: Autologous immune response to the major oncornavirus polypeptides in unmanipulated AKR/J mice.J. Virol., 18: 176–181, 1976.
47.
PetersR.L., HartleyJ.W., SpahnG.J., RabsteinL.S., WhitmireC.E., TurnerH.C., HuebnerR.S.: Prevalence of the group specific (gs) antigen and infectious virus expression of the murine C-type RNA viruses during the life span of BALB/c Cr mice.Int. J. Cancer, 10: 283–289, 1972.
48.
PierottiM.A., ColnaghiM.I.: Natural antibodies directed against murine lymphosarcoma cells: Variability of level in individual mice.Int. J. Cancer, 18: 223–229, 1976.
SchwartzR.S., DonnellyT., MeliefC.J.M., LouieS.: Immunity to C-type RNA viruses: Antibody formation after natural or deliberate infection.J. Immunol., 116: 657–660, 1976.
51.
StephensonJ.R., PetersR.L., HinoS., DonahoeR. M., LongL.K., AaronsonS.A., KellofG.J.: Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses.J. Virol., 19: 890–892, 1976.
52.
TheofilopoulosA.N., DixonF.J.: The biology and detection of immune complexes.Adv. Immunol., 28: 89–220, 1979.
53.
TodaroG.J.: Evolution and modes of transmission of RNA tumor viruses.Am. J. Pathol., 81: 590–606, 1975.
54.
TodaroG.J.: RNA-tumor-virus genes and trans-forming genes: Patterns of transmission.Br. J. Cancer, 37: 139–158, 1978.
